2m 2m 2m 2m 2m 2m 2m
AKANDA (AKAN)
NASDAQ
$5.53+$0.22 (+4.12%)
Price as of Aug 03, 2026 9:01 AM EDT- $2.9MMarket Cap
- -93.13%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AKANDA (AKAN)
$5.53+$0.22 (+4.12%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 45
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$5.14
$6.12
$5.31
1-Year Range
$0.45
$57.09
$5.31
Latest Close$5.31
Change
-$1.08 (-20.34%)
Volume89,943
Market Cap$2.9M
Shares Outstanding540,841
P/E (TTM)-0.0004
Diluted EPS (TTM)-$14,899.95
Enterprise Value$3.5M
Information as of 07/31/2026
Company Profile
AKANDA CORP
https://www.akandacorp.com$2.9M
Market Cap
-$45.7M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
100 King St. W, Toronto, ON, Canada, M5X 1G5
416 862 7525Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.
Key Executives
- Katharyn Field
- Edgar Contreras
- Gurcharn Deol
- Francisco Juarez
Current Ownership Distribution
- Mutual Funds725,529 (50.72%)
- Institutions697,158 (48.74%)
- Insiders7,816 (0.55%)
- Other0 (0.00%)